Skip to main content

BioAtla, Inc.

BCAB
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001826892

No open-market purchases or sales by BioAtla, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.22M in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in BioAtla, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
36
−3 vs. Q4 2025
Shares held
15.7M
+4.44M (+39.5%) vs. Q4 2025
Total value
$2.52M
−$3.87M (−60.6%) vs. Q4 2025
New holders
8
9 more added
Sold out
11
9 more reduced

2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BCAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 36 institutions
Q1 2021: 62 institutionsQ2 2021: 76 institutionsQ3 2021: 87 institutionsQ4 2021: 81 institutionsQ1 2022: 97 institutionsQ2 2022: 80 institutionsQ3 2022: 73 institutionsQ4 2022: 91 institutionsQ1 2023: 81 institutionsQ2 2023: 87 institutionsQ3 2023: 82 institutionsQ4 2023: 79 institutionsQ1 2024: 84 institutionsQ2 2024: 80 institutionsQ3 2024: 65 institutionsQ4 2024: 67 institutionsQ1 2025: 43 institutionsQ2 2025: 39 institutionsQ3 2025: 43 institutionsQ4 2025: 41 institutionsQ1 2026: 36 institutionsQ2 2026: 21 institutions
Value heldQ1 2026: $2.52M
Q1 2021: $964.6MQ2 2021: $897.0MQ3 2021: $746.4MQ4 2021: $518.4MQ1 2022: $127.7MQ2 2022: $67.1MQ3 2022: $191.5MQ4 2022: $279.2MQ1 2023: $87.6MQ2 2023: $96.1MQ3 2023: $51.3MQ4 2023: $66.6MQ1 2024: $87.2MQ2 2024: $30.4MQ3 2024: $31.0MQ4 2024: $14.2MQ1 2025: $4.77MQ2 2025: $5.21MQ3 2025: $9.19MQ4 2025: $7.49MQ1 2026: $2.52MQ2 2026: $1.22M
Institutions holding BCAB and their total value by quarter
QuarterHoldersValue
Q2 202621$1.22M
Q1 202636$2.52M
Q4 202541$7.49M
Q3 202543$9.19M
Q2 202539$5.21M
Q1 202543$4.77M
Q4 202467$14.2M
Q3 202465$31.0M
Q2 202480$30.4M
Q1 202484$87.2M
Q4 202379$66.6M
Q3 202382$51.3M
Q2 202387$96.1M
Q1 202381$87.6M
Q4 202291$279.2M
Q3 202273$191.5M
Q2 202280$67.1M
Q1 202297$127.7M
Q4 202181$518.4M
Q3 202187$746.4M
Q2 202176$897.0M
Q1 202162$964.6M

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding BioAtla, Inc.; share changes are against Q4 2025.

Institutions holding BCAB in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Acorn Capital Advisors, LLC5,406,345$865.0K0.25%+571,234+11.8%Added
Millennium Management LLC2,756,674$443.8K0.00%+1,994,280+261.6%Added
Vanguard Capital Management LLC1,649,252$265.5K0.00%+1,649,252New
Acadian Asset Management LLC1,233,919$198.0K0.00%+476,248+62.9%Added
Geode Capital Management, LLC689,182$111.0K0.00%+188,854+37.7%Added
Deutsche Bank AG525,352$84.1K0.00%−10.0%Reduced
Renaissance Technologies LLC510,514$82.2K0.00%−196,700−27.8%Reduced
BlackRock, Inc.480,931$77.4K0.00%−20.0%Reduced
Citadel Advisors LLC435,675$70.1K0.00%+435,675New
UBS Group AG375,569$60.5K0.00%+149,885+66.4%Added
Marshall Wace, LLP277,630$44.4K0.00%−613,950−68.9%Reduced
Vanguard Fiduciary Trust Co273,427$44.0K0.00%+273,427New
ADAR1 Capital Management, LLC228,107$36.7K0.00%+45,000+24.6%Added
State Street Corp151,377$24.4K0.00%00.0%Unchanged
Northern Trust Corp103,494$16.7K0.00%00.0%Unchanged
Simplex Trading, LLC73,901$11.9K0.00%−46,490−38.6%Reduced
Stonepine Capital Management, LLC65,387$10.5K0.01%+65,387New
XTX Topco Ltd56,614$9.12K0.00%−3,781−6.3%Reduced
Morgan Stanley55,426$8.92K0.00%+11,773+27.0%Added
MAI Capital Management51,504$8.29K0.00%00.0%Unchanged
Kestra Advisory Services, LLC44,250$7.12K0.00%+44,250New
Susquehanna International Group, LLP39,056$6.29K0.00%−42,631−52.2%Reduced
StoneX Group Inc.29,466$4.74K0.00%+29,466New
Commonwealth Equity Services, LLC25,300$4.07K0.00%00.0%Unchanged
Jane Street Group, LLC23,142$3.73K0.00%−323,632−93.3%Reduced
Magnus Financial Group LLC20,000$3.22K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)16,996$2.74K0.00%+11,678+219.6%Added
Vanguard Global Advisers, LLC16,635$2.68K0.00%+16,635New
Mariner, LLC16,000$2.58K0.00%+16,000New
Torrey Growth & Income Advisors15,687$2.36K0.00%00.0%Unchanged
SBI Securities Co., Ltd.11,124$1.79K0.00%+2,334+26.6%Added
Twin Lakes Capital Management, LLC7,200$1.16K0.00%−1,800−20.0%Reduced
Jones Financial Companies LLLP2,000$3060.00%00.0%Unchanged
Advisor Group Holdings, Inc.500$800.00%00.0%Unchanged
BNP Paribas Arbitrage, SA472$760.00%00.0%Unchanged
JPMorgan Chase & Co129$200.00%00.0%Unchanged
Two Sigma Investments, LP0$00.00%−81,330−100.0%Sold out
PVG Asset Management Corp0$00.00%−69,000−100.0%Sold out
HRT Financial LP0$00.00%−54,742−100.0%Sold out
Virtu Financial LLC0$00.00%−55,460−100.0%Sold out
Columbia Advisory Partners LLC0$00.00%−26,070−100.0%Sold out
Global Wealth Strategies & Associates0$00.00%−13,769−100.0%Sold out
HighTower Advisors, LLC0$00.00%−13,000−100.0%Sold out
Arcadia Investment Management Corp0$00.00%−1,403−100.0%Sold out
Tucker Asset Management LLC0$00.00%−500−100.0%Sold out
Bank of America Corp0$00.00%−432−100.0%Sold out
Avion Wealth0$00.00%−490−100.0%Sold out
Vanguard Group Inc––––Not filed
CIBC Private Wealth Group, LLC––––Not filed